Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance
Authors:
- E. MontassierEME. Montassier
- E. BatardEBE. Batard
- M. F. CochetièreMCM. F. Cochetière
- 25 January 2013
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 32 (7) , 841-850
Abstract
Bacteremia remains a major cause of life-threatening complication in patients with cancer. Significant changes in the spectrum of microorganisms isolated from blood culture have been reported in cancer patients over the past years. The aim of our systematic review was to inventory the recent trends in epidemiology and antibiotic resistance of microorganisms causing bacteremia in cancer patients. Data for this review was identified by searches of Medline, Scopus and Cochrane Library for indexed articles and abstracts published in English since 2008. The principal search terms were: “antimicrobial resistance”, “bacteremia”, “bacterial epidemiology”, “bloodstream infection”, “cancer patients”, “carbapenem resistance”, “Escherichia coli resistance”, “extended-spectrum β-lactamase producing E. coli”, “febrile neutropenia”, “fluoroquinolone resistance”, “neutropenic cancer patient”, “vancomycin-resistant Enterococcus”, and “multidrug resistance”. Boolean operators (NOT, AND, OR) were also used in succession to narrow and widen the search. Altogether, 27 articles were selected to be analyzed in the review. We found that Gram-negative bacteria were the most frequent pathogen isolated, particularly in studies with minimal use of antibiotic prophylaxis. Another important trend is the extensive emergence of antimicrobial-resistant strains associated with increased risk of morbidity, mortality and cost. This increasing incidence of antibiotic resistance has been reported in Gram-negative bacteria as well as in Gram-positive bacteria. This exhaustive review, reporting the recent findings in epidemiology and antibiotic resistance of bacteremia in cancer patients, highlights the necessity of local continuous surveillance of bacteremia and stringent enforcement of antibiotic stewardship programs in cancer patients.Keywords
This publication has 56 references indexed in Scilit:
- Fluoroquinolones, antimicrobial resistance and neutropenic cancer patientsCurrent Opinion in Infectious Diseases, 2011
- Bacterial infection profiles in lung cancer patients with febrile neutropeniaBMC Infectious Diseases, 2011
- The Changing Epidemiology of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) RecipientsTransplantation and Cellular Therapy, 2010
- High incidence of methicillin‐resistant Staphylococcus aureus sepsis and death in patients with febrile neutropenia at Royal Darwin HospitalInternal Medicine Journal, 2009
- Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignanciesJournal of Infection, 2009
- Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive studyBMC Infectious Diseases, 2008
- Management of Fever in Neutropenic Patients with Different Risks of ComplicationsClinical Infectious Diseases, 2004
- Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 2000
- Changing Epidemiology of Infections in Patients with Neutropenia and Cancer: Emphasis on Gram-Positive and Resistant BacteriaClinical Infectious Diseases, 1999
- Bacterial isolates in neutropenic febrile patients.1991